Fifteen students from West Chester University (WCU) recently returned from an intensive nine-day study abroad program in ...
Clinical data highlight survival benefits and improvement in functional motor outcomes associated with treatment with doxecitine (dC) and ...
UCB, a global biopharmaceutical company, today announced positive data from studies involving its investigational pyrimidine nucleoside therapy, doxecitine (dC) and doxribtimine (dT), in people living ...
Inquirer Opinion on MSN4d
Rizal in Belgium
Brussels—It only dawned on me as I got off the plane from Manila that this is my third trip to Brussels and I have not ...
Phase 2 clinical trial will be presented at the International Symposium on Intensive Care and Emergency Medicine (ISICEM) conference in Brussels, ...
On 3 April 2024, the Company announced publication of the results of the RED DESERT and SAHARA proof-of-concept studies, in the prestigious peer-reviewed journal European Journal of Heart Failure.